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The global obesity epidemic has heightened the need for an improved understanding of how body weight is
controlled, and research using mouse models is critical to this effort. In this perspective, we provide
a conceptual framework for investigation of feeding behavior in this species, with an emphasis on factors
that influence study design, data interpretation, and relevance to feeding behavior in humans. Although
we focus on themouse, the principles presented can be applied tomost other animal models. This document
represents the current consensus view of investigators from the National Institutes of Health (NIH)-funded
Mouse Metabolic Phenotyping Centers (MMPCs).Introduction
Mouse models have emerged as the tool
of choice for basic research into obesity
pathogenesis for a variety of reasons.
Many key humoral signals (e.g., leptin,
ghrelin) and neuronal circuits (e.g., the
melanocortin system) involved in energy
homeostasis were originally discovered
and characterized in mice and subse-
quently were proven to be critical in hu-
mans as well (Farooqi and O’Rahilly,
2008). As in humans, obesity in mice
can arise either from monogenic disor-
ders or from complex interactions
between genetic background; maternal-
fetal environment; learned behaviors;
and external environmental variables
such as diet composition, ambient
temperature, threats from predators,
and so on. This sensitivity to external vari-
ables is a feature shared by many other
types of behavior—what sets food inges-
tion apart is both the extent of its biolog-
ical regulation and, since excessive food
intake is essential to the pathogenesis of
common forms of obesity, the enormous
price tag linked to defects in this regula-
tory process.
These considerations highlight both the
importance of food intake studies in
mouse models and the potential for such
studies to be confounded by variables
not anticipated when the study was
conceived. The goal of this perspective
article is to offer guidelines to aid in the10 Cell Metabolism 12, July 7, 2010 ª2010 Edesign, analysis, and interpretation of
studies of feeding behavior in mice.
Separating Primary from Secondary
Feeding Responses
An important overarching consideration
that can usefully inform study design is
the context within which a change of
food intake is observed. In mice as in hu-
mans, body adiposity is determined not
by passive accumulation of excess calo-
ries as fat, but by active and upward rere-
gulation of the defended level of body fat
stores, a feature that makes obesity an
especially challenging biological and ther-
apeutic problem. When investigating
a mouse model characterized by
increased food consumption, therefore,
a key initial question is whether the
feeding effect is a direct consequence of
the experimental intervention or rather is
a secondary, compensatory response.
Besides guiding study design, the answer
to this question will place limits on the
information likely to be obtained from
studies aimed at identifying underlying
mechanisms.
When hyperphagia occurs in the
context of weight maintenance or weight
loss, it is likely secondary to either
increased energy expenditure or to the
loss of energy from the body through
other mechanisms (e.g., though glycos-
uria in uncontrolled diabetes mellitus). In
such settings, increased food intakelsevier Inc.reflects a properly functioning regulatory
system, and while mechanistic feeding
studies can shed light on how the normal
system responds to a defined challenge,
the underlying mechanisms are likely to
differ from those driving hyperphagia in
conditions associated with obesity.
Hyperphagia associated with uncon-
trolled diabetes is a secondary manifesta-
tion of a metabolic disease and as such
provides a useful paradigm for how
to identify and distinguish primary from
secondary feeding responses. Evidence
supporting the interpretation of ‘‘diabetic
hyperphagia’’ as a secondary response
includes the following: it arises in conjunc-
tion with progressive loss of adipose
mass, is detectable only after body weight
and fat content have begun to decrease,
and is ameliorated by restoring plasma
concentrations of key regulatory
hormones (insulin and leptin) from
dramatically reduced back to normal
values (Havel et al., 1998; Sindelar et al.,
1999). Although study of this phenom-
enon has helped to clarify mechanisms
linking a change in hormonal and
metabolic milieu to the control of feeding
behavior, such insights cannot be relied
upon to pertain to other conditions in
which food intake is increased (e.g., in
response to a genetic perturbation or
exposure to a highly palatable diet), and
this consideration can inform study
design.
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priate when body fat mass is depleted
and leptin levels consequently reduced,
it follows that apparently ‘‘normal’’ intake
(e.g., the absence of hyperphagia) can
sometimes be indicative of an altered
regulatory system. In mice bearing a tar-
geted mutation that causes a ‘‘lean,
hypermetabolic’’ phenotype, for example,
comparisons of food intake to genetically
normal controls must take into consider-
ation the normal feeding response to
reduced body energy stores (Gelling
et al., 2008). If mutant mice do not
increase their intake relative to that ex-
pected in wild-type (WT) controls that
have experienced a comparable
decrease of body adiposity, this may be
indicative of changes in the capacity of
the animal to mount an appropriate hyper-
phagic response. Alternatively, it may be
that regulatory responses are intact, but
that the threshold for eliciting them has
been altered. These possibilities can be
distinguished from one another by deter-
mining whether the mutant mice are able
to mount an appropriate hyperphagic
response to a further lowering of body
weight (e.g., induced by caloric restric-
tion). If so, the mutation may have ‘‘reset’’
the defended level of body adiposity at
a reduced value. One potential mecha-
nism to explain this outcome would be
an increase of leptin sensitivity, such
that food is consumed in ‘‘normal’’
amounts (e.g., comparable to WT values)
in a setting of low circulating leptin levels.
Studies could then be undertaken to test
this hypothesis and investigate underlying
mechanisms, rather than simply
concluding that the mutation did not
affect food intake (as tends to occur
when food intake is not different between
experimental and control groups).
Analysis of Food Intake
in the Setting of ExcessWeight Gain
When hyperphagia is observed in the
context of obesity, a logical inference is
that the latter is due, at least in part, to
the former, and study design is again
informed by this interpretation. For
example, the extent to which excessive
body weight gain is due to increased
food intake can be investigated using
a pair-feeding paradigm (see the Supple-
mental Information, Supplemental Assay
Protocols, available online), in which the
ability of affected mice to consume foodin excess of that eaten by nonobese
controls is prevented. Feed efficiency,
defined as the ratio of calories consumed
divided by body weight gain over
a specific time interval, can offer addi-
tional insight into how ingested fuel is
utilized and as such can aid in the assess-
ment of whether an alteration in energy
expenditure or nutrient absorption
contributes to a body weight phenotype.
One may also wish to investigate
whether the mechanism(s) underlying
hyperphagia in obese mice involves (1)
a defect in homeostatic control mecha-
nisms that match energy intake to expen-
diture over long time intervals, (2) an exag-
gerated response to the rewarding
properties of food, (3) an impairment in
the ability of meal-related satiation signals
to effectively terminate meals once they
have begun, or some combination
thereof. Distinguishing among these
various possibilities requires decisions
about which feeding assays will be most
informative with respect to underlying
mechanism(s) and can thereby guide
subsequent studies seeking to identify
the brain regions, neurocircuits, and
signaling molecules involved.
When using increased body weight as
a framework within which to investigate
mechanisms of hyperphagia, it is impor-
tant to appreciate that ‘‘not all instances
of weight gain are equal.’’ Elevated food
intake and body weight occur not only in
obese animals but in the context of accel-
erated linear growth as well. To
distinguish between these two, body
composition and body length should be
assessed before studies to investigate
underlying mechanisms are undertaken.
If accelerated linear growth, rather than
obesity, is the cause of increased body
weight gain, hyperphagia in this setting
is more likely to be an appropriate, adap-
tive response than the primary mecha-
nism driving the phenotype (in contrast
to what is observed in many forms of
obesity).
A related question that often arises is
whether measurements of food intake
should be normalized to body weight, as
is often done with measures of energy
expenditure. We offer two arguments in
opposition to this practice for the analysis
of food intake data. The first is that differ-
ences in body weight can reflect differ-
ences in lean body mass, fat mass, or
both; consequently, normalized intakeCell Metabolvalues must be interpreted differently
when comparing obese and lean animals.
Second, normalizing by simple division
makes assumptions about the nature of
the relationship between intake and
body weight that have yet to be validated.
Specifically, normalizing food intake in
this way presumes that intake is regulated
as a function of changes in body weight,
whereas the reverse is commonly the
case. As one extreme example, intake
normalized to body weight can lead to the
conclusion that leptin-deficient lepob/
lepob mice are either hypophagic or
hyperphagic relative to WT controls, de-
pending on the age at which measure-
ments are made, even if absolute intake
is unchanging. This is because when the
mice are young, the relative increase of
intake exceeds the weight increase; as
weight continues to increase with age,
however, it eventually exceeds the
increase of intake, relative to controls.
Yet comparisons of absolute (i.e., nonnor-
malized) intake reveal lepob/lepob mice
to be hyperphagic relative to controls at
any age. Including body weight and/or
composition data in the figure legend
when food intake is reported may help to
minimize misinterpretation of nonnormal-
ized food intake data.
When group differences in body weight
reflect differences of age, gender, or
linear growth, meaningful comparisons
of intake tend to be confounded regard-
less of whether or how intake data are
normalized. As was recently reported for
the analysis of energy expenditure data
in mice (Kaiyala et al., 2010), multiple
regression may permit insight into
whether an experimental intervention
affects intake after adjusting for differ-
ences of other variables, but such an
approach awaits validation in a large
cohort of mice. Until such an analysis
has been undertaken, we suggest that
quantitative comparisons of food intake
can be inherently misleading and should
therefore be avoided under certain cir-
cumstances (e.g., when an experimental
intervention is undertaken that compares
groups of old versus young or male versus
female mice).
Limitations
A key issue that should be considered
when planning experiments is that
feeding assays can lack the sensitivity
needed to identify differences in energyism 12, July 7, 2010 ª2010 Elsevier Inc. 11
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less affect body fat mass over time.
Even the most sensitive assay tools
cannot be relied upon to detect group
mean differences of intake below 10%
on a day-to-day basis in mouse models,
yet such differences, if they persist, can
substantially influence body weight and
fat content. As reviewed in the Supple-
mental Information, the ability to detect
small differences of daily intake can be
increased by comparing cumulative
values measured over long time intervals,
rather than relying solely on daily
measures. Of course, many other limita-
tions to the use of mouse models to study
feeding behavior exist and are highlighted
throughout the discussion below.
Basic Considerations when
Designing a Study
Because behavioral and metabolic
responses in mice are highly sensitive to
genetic and environmental factors, even
subtle aspects of an experimental para-
digm can influence feeding and other
pertinent measures (Bailey et al., 2006;
Champy et al., 2004, 2008; Crabbe
et al., 1999; Mandillo et al., 2008)
(Figure S1). Some of these factors are dis-
cussed below.
Choice of Strain
The phenotype resulting from even quite
subtle genetic, dietary, or pharmacolog-
ical manipulations can differ widely de-
pending on the background strain.
Currently, the C57BL/6J background
strain is by far the most commonly used
for energy homeostasis studies in mice,
as this was the first strain to have its
genome completely sequenced (Gregory
et al., 2002) and, in contrast to other
commonly used strains, is relatively
susceptible to diet-induced obesity (DIO;
for review, see Champy et al., 2008;
Collins et al., 2004). Even variation within
substrains such as C57BL/6J versus
C57BL/6N (Bryant et al., 2008; Roth
et al., 2002; Yang et al., 2003) can affect
experimental outcomes. This phenom-
enon is well described in the Jackson
Laboratory publication ‘‘Genetic Back-
ground: Understanding Its Importance
in Mouse-Based Biomedical Research’’
(http://jaxmice.jax.org/manual/index.html).
As one example, the severity of many
aspects of the phenotype of lepob/lepob
mice, including diabetes (Coleman, 1978;
Coleman and Hummel, 1973; Haluzik12 Cell Metabolism 12, July 7, 2010 ª2010 Eet al., 2004; Qiu et al., 2001), fertility
(Ewart-Toland et al., 1999; Qiu et al.,
2001), and adiposity (Qiu et al., 2001),
varies substantially across different
genetic backgrounds. Similarly, predispo-
sition to DIO and associated metabolic
impairments among genetically normal
mice also varies greatly with background
strain. To summarize, variability in key
endpoints (e.g., food intake, body compo-
sition, weight gain, etc.) is increased by
inclusion of more than one background
strain in a given experiment and this, in
turn, can confound the ability to attribute
a change in experimental endpoints to
a specific intervention (e.g., administra-
tion of a drug or targeted gene knockout).
For this reason, studies involving mea-
sures of food intake are usually performed
in mice bred onto a pure background
strain, most often C57BL/6J.
One drawback of using C57BL/6J mice
is that they produce relatively small litters
and thus are not optimal for the produc-
tion of transgenic or knockout animals.
The Animal Models of Diabetic Complica-
tions Consortium (AMDCC) has detailed
phenotypic information for numerous
mouse strains that manifest different dia-
betic complications, including cardiovas-
cular dysfunction, nephropathy, neurop-
athy, retinopathy, and uropathy, in
addition to hyperglycemia and metabolic
impairments, thereby enabling research-
ers to select the animal model that best
mimics the human condition they are
investigating. Numerous online resources
(Table 1) are available to aid in the selec-
tion of an appropriate mouse strain for
a specific study, including phenotypic
and genetic databases.
Beyond these considerations, overreli-
ance on the C57BL/6J strain may yield
a skewed understanding of systems gov-
erning feeding behavior and energy
homeostasis, considering that humans
are not an inbred population. By focusing
on one or another inbred mouse strain to
interpret an anomaly of feeding behavior,
we may therefore limit our understanding
of human physiology, especially for studies
seeking to clarify gene-by-environment
interactions that predispose to obesity.
Rather than systematically excluding the
study of mice with mixed genetic back-
grounds, the argument can be made that
such mice offer an important opportunity
to identify gene variants that affect energy
balance (see Table 1) (Su et al., 2008).lsevier Inc.A number of ongoing gene-targeting
projects (Table 1) such as the European
Conditional Mouse Mutagenesis (EU-
COMM) program and the Knockout
Mouse Project (KOMP) use the C57BL/
6N line as a background strain, a move-
ment that may lead to a switch in the
predominant mouse strain used for
studies on energy homeostasis. Despite
being closely related, there are numerous
genetic polymorphisms that distinguish
C57BL/6N (National Institutes of Health;
NIH) and C57BL/6J (Jackson Laboratory)
substrains (Bryant et al., 2008) and yield
phenotypic differences. Of particular rele-
vance here is that in contrast to the
C57BL/6J line, the C57BL/6N strain
does not carry the nicotinamide nucleo-
tide transhydrogenase (Nnt) deletion that
contributes to impaired glucose homeo-
stasis in C57BL/6J mice (Freeman et al.,
2006; Huang et al., 2006; Toye et al.,
2005).
Genetic Background in Transgenic
and Knockout Mice
When creating a novel transgenic or
knockout mouse strain, initial character-
ization should be performed on animals
bred from heterozygous x heterozygous
pairings. In addition to ensuring that the
WT controls have exactly the same
genetic background, this approach also
controls for differences in in utero environ-
ment and early-life experience. Many
investigators choose to backcross strains
of mixed genetic background to ensure
that their mice remain on a pure congenic
background; alternatively they may opt to
change the genetic background of their
mice to a strain that is more commonly
used for their disease model. The impor-
tant point is that having genetically modi-
fied mice on a pure genetic background
simplifies the interpretation of results
and comparison with published data,
despite inherent limitations noted above.
Although it is generally accepted that
ten or more generations of successive
backcrossing to an inbred strain are
needed to produce a congenic line, this
number is somewhat arbitrary, and the
relative contribution of the original strain
depends upon the breeders selected.
Some companies offer ‘‘speed congenic’’
services, which can accelerate and
improve the accuracy of the backcrossing
process. This service is based on select-
ing those breeders that display the high-
est percentage of genetic similarity to
Table 1. Resources to Help Select a Mouse Strain
Title Link
Phenotype Resources
Mouse Phenome Database http://www.jax.org/phenome/
Europhenome Mouse Phenotyping Resource http://www.europhenome.org/
The Animal Models of Diabetic Complications
Consortium (AMDCC)
http://www.amdcc.org/
Eumorphia http://www.eumorphia.org/
Centre for Modeling Human Disease http://www.cmhd.ca/
Genetics/Genomics Resources
Mouse Genome Informatics Database http://www.informatics.jax.org/
Mouse SNP Database http://mousesnp.roche.com/
Priorities for Mouse Functional Genomic Research
Across Europe (PRIME)
http://www.prime-eu.org/
SOP/Protocol Resources
European Mouse Phenotyping Resource
of Standardised Screens (EMPRESS)
http://www.empress.har.mrc.ac.uk/
Centre for Modeling Human Disease http://www.cmhd.ca/
Mouse/Embryonic Stem Cell Repositories
Riken Bioresource Center http://www.brc.riken.jp/lab/animal/en/
Mutant Mouse Regional Resource Center http://www.mmrrc.org/
The European Mouse Mutant Archive (EMMA) http://www.emmanet.org/
Mousebook (Medical Research Council) http://www.mousebook.org/
North American Conditional Mouse Mutagenesis
Project (NorCOMM)
http://www.norcomm.org/
European Conditional Mouse Mutagenesis
program (EuCOMM)
http://www.eucomm.org/
Knock Out Mouse Project (KOMP) http://www.komp.org/
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number of generations required before
the mice become statistically identical at
all genetic loci to the targeted congenic
strain, except for the modified locus and
genes linked to it (for review, see Wake-
land et al., 1997; Wong, 2002).
Once a genetically modified strain is
bred onto a congenic background, mice
should be outcrossed to a congenic
mouse from the parent strain every eight
to ten generations to reduce genetic drift
and the consequent generation of a new
substrain within a colony. Although not
immune to genetic drift, most commercial
vendors employ rigorous quality control
for each strain, and it is recommended
that commercially sourced mice, as
opposed to ‘‘WT congenics’’ from your
own colony, be used for outcrossing. Yet
despite the best efforts of commercial
vendors to maintain consistency, avail-
able evidence suggests that phenotypic
and behavioral differences exist among
mice of the same strain that are
purchased from different vendors (Bryant
et al., 2008) or even from different facilitiesoperated by the same vendor. Thus, when
mice of the same strain are purchased
from two different vendors, one cannot
assume that they are genetically or
phenotypically identical. We recommend
maintaining consistency in both vendor
and vendor location when purchasing
animals for a series of related studies.
Genetic versus Diet-Induced Obese
Mice
The most commonly used mouse models
of obesity are either genetic (e.g., induced
by a natural or experimentally initiated
mutation) or diet induced, and the model
selected depends on the questions being
asked. For example, generating DIO
mice, as described in detail in the Supple-
mental Information, is time consuming
and can be costly (due to extended
periods of housing), but has the advan-
tage of having greater relevance to
common forms of human obesity than
most monogenic obesity syndromes.
This assertion is based on the fact that,
as in most obese humans, the DIO pheno-
type arises from combined effects of
a polygenic susceptibility and exposureCell Metabolto palatable, calorically dense diets,
especially when the diet is high in fat
and/or refined carbohydrates. Further,
the DIO model allows comparisons
between obese and lean mice that are
genetically identical, thus eliminating
a major source of experimental variability.
DIO C57BL/6 mice are available in limited
numbers from commercial vendors
including The Jackson Laboratory and
Taconic, but vendors typically cannot
provide information about the rate of
weight gain in individual mice.
The most widely used mouse models of
monogenic obesity are lepob/lepob, lepdb/
lepdb, and AY. Because each has been
studied for more than 50 years, consider-
able phenotypic data are available in the
literature for each, and they along with
many other mouse models of genetic
obesity are commercially available. In
addition, several nonprofit organizations
have repositories of mouse stocks as
well as embryonic stem cell (ESC) lines
of previously generated strains that have
interesting phenotypes but are not in suffi-
cient demand to be stocked by commer-
cial vendors. Some of these are listed in
Table 1.
Age and Sex
Male mice are often preferred over
females because many key determinants
of energy balance are affected by
hormonal variation associated with the
estrous cycle (for review, see Asarian,
2006; Fernandez-Fernandez et al., 2006;
Hill et al., 2008). Additionally, like humans,
body composition and body fat distribu-
tion differ between male and female
mice, with mature females having a higher
percentage of body fat, but relatively less
fat deposited within the abdomen, than
males. Consequently, experimental
groups of mixed sexes are not generally
recommended for studies of energy
balance, and male and female animals
should be studied separately, as dis-
cussed earlier. Similarly, age matching is
critical, especially when investigating
mice that are not fully mature.
Stress and Habituation
Mice are easily stressed, and stress per
se influences all aspects of energy
homeostasis, including food intake,
energy expenditure, locomotor activity,
and body composition. Further, whereas
some stressors decrease food intake,
others have the opposite effect (Adam
and Epel, 2007; Tamashiro et al., 2007a,ism 12, July 7, 2010 ª2010 Elsevier Inc. 13
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In addition to designed experimental
stressors such as restraint, forced swim,
or foot shock, stress in mice can also be
induced inadvertently by routine handling;
noise or social isolation; or placement in
a clean home cage, a metabolic cage, or
other experimental apparatus.
The degree of stress experienced by
animals can vary with both the number
of investigators involved in an experiment
and their skill and experience working
with mice (Mandillo et al., 2008). Stress
can therefore be minimized by assigning
responsibility for animal handling to
a single, experienced individual through-
out a study, a key issue when designing
study protocols. Even subtle factors
such as a change in the perfume of an
investigator can be a source of stress.
Many relevant study endpoints in addition
to food intake are also sensitive to stress,
including circulating insulin, glucose, and
corticosterone levels, and it is important
to consider whether reported outcomes
involving these measures are reflective
of stress rather than, or in addition to,
the intended experimental manipulation.
Practical issues related to experimental
stress and its reduction are detailed in
the Supplemental Information.
Energy Intake and Considerations
in Assay Selection
Meal Patterns in Mice
When housed under a standard 12 hr light/
12 hr dark cycle, mice consume the
majority of their food during the dark,
with short bouts of feeding during the light.
Water consumption is strongly linked to
food intake and declines dramatically in
fasted or food-restricted animals. Typical
24 hr food intake for a 7- to 9-week-old
male mouse fed standard chow is 10–12
Kcal/g body weight (mean across 13
strains; Jackson Laboratory, Mouse Phe-
nome Database) with approximately 70%
consumed during the dark. Obese mice
are often hyperphagic and can eat signifi-
cantly more than this, although sustained
consumption of more than twice control
intake is rare. Practical guidelines for the
selection of a feeding paradigm are
provided in the Supplemental Information.
To minimize the impact of variables that
can affect food intake (Figure S1), most
studies of feeding behavior are conducted
in mice that are individually housed;
matched for age, sex, and background14 Cell Metabolism 12, July 7, 2010 ª2010 Estrain; and have unrestricted access to
their diet. Even with these controls in
place, variables such as room tempera-
ture, humidity, and noise can have a major
influence on feeding behavior (Fregly et al.,
1957). Specifically, because the thermo-
neutral temperature for a mouse is 29C–
32C, mice kept at standard vivarium
temperatures such as 22C must expend
extra energy to keep warm, and this in
turn triggers adaptive increases of food
intake. It is noteworthy that advertised
vivarium temperatures are not always
accurate or constant. The effect of even
small fluctuations in ambient temperature
on energy homeostasis is illustrated in
mice that lack uncoupling protein-1
(UCP1), a protein that is expressed in the
mitochondria of brown adipose tissue
(BAT). These mice have a heightened
susceptibility to cold and do not develop
obesity under standard housing condi-
tions (Enerback et al., 1997), but do when
housed at thermoneutrality (Feldmann
et al., 2009). Other parameters such as
food preference and gut flora can also be
affected by experimental pharmacological
and/or genetic manipulations and can
affect study outcomes.
Questions to Consider when
Studying the Feeding Effects
of a Drug Intervention
Does the Compound Alter Normal
Feeding Behavior?
To determine if a candidate compound
affects short-term food intake, measures
of nocturnal feeding are often the first to
be undertaken, especially if the interven-
tion is hypothesized to reduce intake,
since mice eat their largest meals soon
after ‘‘lights off.’’ Dark-cycle readings
can be taken under red light illumination
to avoid disturbing the animals, and intake
should be monitored at regular intervals
throughout the dark period to uncover
acute effects on satiation or satiety. For
example, a compound that induces satia-
tion may reduce the size of an initial meal
but no others, whereas a compound that
increases satiety may prolong the inter-
meal interval. However, neither of these
effects may be detectable if the only
measure obtained is 24 hr food consump-
tion, since mice compensate for early
reductions of energy intake by eating
more later on. As one example, exoge-
nous administration of the gut peptide
cholecystokinin (CCK) potently reduceslsevier Inc.intake for 30–60 min, followed by a subse-
quent, compensatory increase of intake
(Moran and Kinzig, 2004). When investi-
gating such short-acting compounds,
intake should be assessed every 30 min
for the first 2 or 3 hr. When applying
procedures that act over longer intervals
(e.g., exogenous leptin), hourly or even
daily assessments can be used. Assess-
ing these parameters is greatly facilitated
by use of automated feeding systems that
require no investigator intervention.
Fasting-induced feeding can also be
used for investigating anorexigenic
compounds. In a typical paradigm, mice
are fasted for a fixed period such as 4–6
hr or longer (e.g., overnight), and the return
of food is preceded by administration of
the test compound or other procedure. In
normalmice,fastingtriggersahyperphagic
response during the refeeding period (rela-
tive to free-feeding mice) that lasts several
hours and can aid in the detection of
reduced intake; as body energy stores
are replenished, intake returns to normal,
and detection of milder forms of anorexia
may become problematic.
The important point is that the best time
of day for measuring food intake depends
upon the question being asked. If a treat-
ment is hypothesized to reduce short-
term intake, the test will be more sensitive
if intake at baseline is relatively high. Con-
ducting the test in the dark or withholding
food prior to the test increases the base-
line value and may therefore simplify
detection of modest feeding effects.
Conversely, if a treatment is hypothesized
to increase acute intake (e.g., adminis-
tering the hormone ghrelin), it can be
advantageous to have a lower baseline
value. This can be accomplished by
a shorter period of deprivation and/or by
conducting the test during the light cycle
when mice eat less. A final consideration
is that due to their relatively high meta-
bolic rate, a 12–16 hr fast is a major
stressor, and longer periods of fasting
are not recommended because of their
potent effects on feeding behavior. In
general, water should be freely available
at all times when feeding is assessed.
Does the Compound Reduce Food
Intake through a Homeostatic
Mechanism? Anorexia versus
Aversion
In addition to interventions that
impinge upon neurocircuits governing
homeostatic food intake control, food
Figure 1. A Sample Decision-Making Chart for Assessment of the Effect of a Drug/
Compound on Energy Intake
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stress (noted above), sickness, or drug
toxicity. Once a test compound is shown
to reduce food intake, therefore, additional
studies may be warranted to determine
whether a nonhomeostatic mechanism
underlies the effect. The terminology
used here is necessarily explicit, and the
terms ‘‘physiological’’ and ‘‘nonphysio-
logical,’’ and ‘‘specific’’ and ‘‘nonspe-
cific,’’ are avoided since reductions of
food intake caused by sickness-like
behavior in mice may be induced via the
same receptors or neuronal circuitry that
induce satiation. As an example, CCK is
secreted during every meal, and while
administration of small doses of exoge-
nous CCK reduce food intake without
aversive effects (Gibbs and Smith, 1977),
higher doses are associated with aversive
or sickness-like behavior (Deutsch and
Hardy, 1977; Perez and Sclafani, 1991).
Thus, satiation and sickness-induced
reductions of food intake may exist along
a continuum with illness/nausea repre-
senting one extreme. Although rodents
lack the emetic reflex (i.e., they cannot
vomit), ‘‘sickness-like’’ behavior can
manifest itself as a spiky coat or hunched
posture, altered breathing rate, labored
movements, reduced activity, and/or
subdued behavior. Two well-character-
ized behavioral assays, conditioned taste
aversion (CTA) and pica (a disorder of
feeding behavior characterized by
increased consumption or chewing of
nonfood materials), are commonly em-ployed to assess whether a reduction in
food intake is a manifestation of malaise.
For a detailed description of how to
perform CTA and pica tests and the rela-
tive merits of these tools for assessing
sickness-like behavior in rodents, see the
Supplemental Assay Protocols section of
the Supplemental Information and An-
drews and Horn (2006).
Does the Compound Affect Energy
Balance Independently of Food
Intake?
Pair feeding is a technique in which the
amount of food provided to a control
group of mice is matched to that
consumed by the experimental group, so
as to determine the extent to which the
effect of a treatment on body weight or
body composition occurred indepen-
dently of changes of energy intake (Dubuc
et al., 1984; Levin et al., 1996). If body
weight is reduced to a greater extent in
treated mice than in controls fed the exact
same amount of food, this outcome is
suggestive of a change in metabolic rate
elicited by the treatment, which could
subsequently be verified by indirect calo-
rimetry. Because pair-fed mice consume
the same test diet as experimental mice,
but in lesser amounts, factors such as
macronutrient content and palatability
are also controlled. Additional details and
limitations regarding pair feeding are
provided in the Supplemental Information.
In summary, decisions about when and
how food intake is to be measured should
be made only after considering a variety ofCell Metabolparameters including diet and time of day,
how often to take readings, and whether
the animals should be fed or fasted prior
to food presentation. A sample decision-
making chart for assessing the effect of
a compound/intervention on feeding
behavior is shown in Figure 1. In addition,
assessment of potential illness should be
considered for novel interventions that
reduce intake, and pair-fed controls can
be used to differentiate reduced feeding
from other causes of weight loss.
Questions to Consider when
Analyzing Feeding Behavior
in Genetically Modified Mice
Is Food Intake Normal in My Model?
If a genetically modified mouse weighs
more or less than controls, a reasonable
first step in characterizing the phenotype
is to assess food intake as described
above. When increased food intake is
observed in the context of obesity, the
investigative approach can focus on
whether the underlying mechanism
involves a defect in homeostatic control,
in the perception of satiating or rewarding
properties of food, or in other mecha-
nisms. When increased food intake is
observed in the context of reduced body
weight or fat mass (e.g., in mice with
a lean, hypermetabolic phenotype), the
mechanisms driving intake may be
compensatory in nature and in fact reflect
a properly operating regulatory system.
A simple test to determine whether
a homeostatic regulation of food intake
is intact is to measure fasting-induced re-
feeding. In this assay, animals are fasted
during a period of high baseline consump-
tion (usually overnight) and then refed,
and their intake is measured until body
weight returns to prefasted values
(usually, within 2–3 days). Animals nor-
mally consume large meals during this re-
feeding period to correct for their negative
energy balance, and failure to refeed nor-
mally may indicate a defect in this homeo-
static response. Alternatively, excessive
refeeding hyperphagia may be indicative
of altered satiation pathways or other
changes affecting the control of feeding
behavior.
Another assay that can be used to
investigate whether normal homeostatic
feeding is intact is to examine the
response to a high-fat diet (HFD; see the
Supplemental Information). Normal mice
become hyperphagic within 48 hr ofism 12, July 7, 2010 ª2010 Elsevier Inc. 15
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Perspectiveexposure to a HFD and begin to gain body
weight beyond that of control values
within the first 1–2 weeks, and caloric
intake often returns toward normal levels
after this initial period of hyperphagia
(when making such measurements, it is
important to monitor calorie intake, rather
than food consumption in grams, since
the high-fat and control low-fat diets typi-
cally differ in energy density). Failure to
exhibit the gradual normalization of
energy intake as body weight and fat
mass increase on a HFD may indicate an
alteration in homeostatic control of food
intake, as occurs in mice with impaired
melanocortin signaling (Butler et al.,
2001).
Is the Body Weight/Composition
Phenotype Dependent on Altered
Feeding Behavior?
A simple means of establishing whether
reduced food intake is responsible for
a phenotype of lowered body weight is
to use pair feeding as described above.
If a genetically altered mouse is both
hyperphagic and obese, restricting the
intake of a cohort of these animals to
match that consumed by WT controls
sheds light on the extent to which the
obesity is due to excessive intake, while
keeping in mind precautions described
in the Supplemental Information. If the
results of this type of pair-feeding study
indicate that differences of caloric intake
per se cannot fully account for observed
changes of body weight, a useful next
step is to measure energy expenditure
by indirect calorimetry.
The Mouse as a Model of Human
Feeding Behavior
Ultimately, information gained from anal-
ysis of feeding behavior in mice is most
useful if it sheds light on human physi-
ology and/or pathophysiology, and many
observations support this view. As noted
earlier, monogenic causes of human
obesity have been identified principally
on the basis of mouse models (Farooqi
and O’Rahilly, 2008). Of therapeutic rele-
vance is that many drug targets under
investigation for the treatment of human
obesity were originally identified and
characterized in mouse models. Con-
versely, genome-wide association stud-
ies have identified variation in genes
previously characterized as participating
in the central nervous system control of
food intake in mice (e.g., Sh2b1) as being16 Cell Metabolism 12, July 7, 2010 ª2010 Eassociated with human obesity (Ren et al.,
2007; Willer et al., 2009). Lastly, the ease
with which modern genetic and pharma-
cological tools are applied to mouse
models supports their application to the
study of human obesity pathogenesis
and treatment.
This being said, there are many obvious
and important differences in feeding
behavior between mice and humans.
Laboratory mice are nocturnal and
consume most of their food in frequent,
small meals throughout the dark. By
comparison, humans tend to consume
most of their calories in three or four meals
during the light. The extent to which this
pattern of human feeding behavior has
evolved due to social constraints is an
open question—the observation that
rodents are readily trained to receive their
food in discrete meals in meal-entrain-
ment studies suggests that this aspect
of feeding behavior can be strongly influ-
enced by learned variables.
Another pertinent issue is eating for
physiological versus psychological need.
Humans are strongly predisposed to alter
patterns of food consumption in response
to a wide range of emotional states, with
one consequence being that altered
feeding patterns are common features of
psychiatric illness. Perhaps even more
obvious is the volitional aspect of feeding
behavior—deliberately choosing to eat or
not—which may be a uniquely human
quality. As such, it can be argued that
feeding behavior in humans is uniquely
complex and that mouse models areuseful
primarily to study physiological aspects of
feeding behavior after psychological
considerations have been stripped away.
Even this assertion can be challenged,
however, since the determinants of
energy balance in mice differ substantially
from those in humans. Mice have a much
higher surface area to volume ratio than
humans, requiring them to expend
a greater proportion of their daily energy
budget to maintain core temperature.
Consequently, changes of ambient
temperature have a greater impact on
energy demands in rodents, and this in
turn can strongly affect feeding behavior,
as discussed earlier. Another difference
is that rodents lack an emetic reflex,
which complicates the study of aversion
and drug toxicology.
In a recent provocative perspectives
article, Martin and colleagues argue thatlsevier Inc.due to their generally sedentary lives in
a nutrient-rich environment, many of the
‘‘control’’ laboratory rodents used in
research studies are in fact metabolically
morbid, which may skew data interpreta-
tion (Martin et al., 2010). They state that
by human standards most laboratory
rodents are in relatively poor health and
that a second control group of animals
that have access to increased exercise
and/or more limited food should be
included in many studies to represent
the ‘‘healthy’’ human population.
Conclusions
This document represents the opinions of
the investigators from the various NIH-
funded MMPCs. It is a working document
and will be updated from time to time to
incorporate the knowledge we acquire
through the performance of studies with
WT, knockout, and transgenic animals.
For alternative points of view and for
coverage of relevant aspects of mouse
phenotyping not covered in this article,
we also refer readers to the EUMORPHIA
(http://www.eumorphia.org/), a European
consortium of 18 research institutes
across eight countries developing and
validating standard operating protocols
(SOPs), as well as the following books:
Fox et al. (2006), Hedrich (2004), and
Hrabe De Angelis et al. (2006).
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure, two
tables, supplemental assay protocols, and Supple-
mental References and can be found with this
article online at doi:10.1016/j.cmet.2010.06.001.
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